These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog. Nichols AJ; Koster PF; Brooks DP; Ruffolo RR J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161 [TBL] [Abstract][Full Text] [Related]
65. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog. Woodman OL; Vatner SF J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177 [TBL] [Abstract][Full Text] [Related]
66. Role of prejunctional beta adrenoceptors in rat cardiac sympathetic neurotransmission. Apparsundaram S; Eikenburg DC J Pharmacol Exp Ther; 1995 Feb; 272(2):519-26. PubMed ID: 7853165 [TBL] [Abstract][Full Text] [Related]
67. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. Kerns WD; Arena E; Morgan DG Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297 [TBL] [Abstract][Full Text] [Related]
68. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs. Seymour AA; Blaine EH Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):304-15. PubMed ID: 6148046 [TBL] [Abstract][Full Text] [Related]
69. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed. Van der Niepen P; Lefebvre RA; Dupont AG J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108 [TBL] [Abstract][Full Text] [Related]
70. Inhibition of canine adrenergic transmission by an analog of dopamine: GJH-166. Sharabi FM; Long JP; Cannon JG J Pharmacol Exp Ther; 1977 Jul; 202(1):97-104. PubMed ID: 195039 [TBL] [Abstract][Full Text] [Related]
71. Comparison of the cardiovascular actions of dopamine and epinine in the dog. Itoh H; Kohli JD; Rajfer SI; Goldberg LI J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584 [TBL] [Abstract][Full Text] [Related]
72. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats. McCoy CE; Douglas FL; Goldberg LI Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024 [TBL] [Abstract][Full Text] [Related]
73. Evidence against a role for dopamine D1 receptors in the myocardium of the pig. Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206 [TBL] [Abstract][Full Text] [Related]
74. Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium. Rump LC; Riera-Knorrenschild G; Schwertfeger E; Bohmann C; Spillner G; Schollmeyer P J Cardiovasc Pharmacol; 1995 Sep; 26(3):462-70. PubMed ID: 8583789 [TBL] [Abstract][Full Text] [Related]
76. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine. Lass NA; Glock D; Goldberg LI Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941 [TBL] [Abstract][Full Text] [Related]
77. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat. Van der Niepen P; Schoors DF; Dupont AG Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774 [TBL] [Abstract][Full Text] [Related]
78. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058. Brooks DP; Mitchell MP; Short BG; Ruffolo RR; Nichols AJ J Pharmacol Exp Ther; 1991 Jun; 257(3):1243-7. PubMed ID: 1675291 [TBL] [Abstract][Full Text] [Related]